Effects of Exercise on Motivational Outcomes in Rectal Cancer Patients During and After Neoadjuvant Chemoradiation: A Phase II Randomized Controlled Trial

被引:2
|
作者
Arthuso, Fernanda Z. [1 ]
Morielli, Andria R. [1 ]
Usmani, Nawaid [2 ,3 ]
Joseph, Kurian [2 ,3 ]
Nijjar, Tirath [2 ,3 ]
Tankel, Keith [2 ,3 ]
Fairchild, Alysa [2 ,3 ]
Severin, Diane [2 ,3 ]
Boule, Normand G. [1 ]
Courneya, Kerry S. [1 ]
机构
[1] Univ Alberta, Coll Hlth Sci, Fac Kinesiol Sport & Recreat, Edmonton, AB T6G 2H9, Canada
[2] Univ Alberta, Coll Hlth Sci, Dept Oncol, Edmonton, AB, Canada
[3] Cross Canc Inst, Div Radiat Oncol, Edmonton, AB, Canada
基金
加拿大健康研究院;
关键词
Rectal Cancer; Chemoradiation Therapy; Exercise; Motivation; Theory of Planned Behavior; AEROBIC EXERCISE; UNDERSTANDING EXERCISE; RESISTANCE EXERCISE; CHEMOTHERAPY; SURVIVORS; IMPACT;
D O I
10.1016/j.soncn.2023.151419
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives: Understanding exercise motivation in rectal cancer patients during and after neoadjuvant chemo-radiation therapy is important to improve adherence and achieve potential benefit. We report the motivational effects of exercise from the Exercise During and After Neoadjuvant Rectal Cancer Treatment trial.Data Sources: We randomized 36 rectal cancer patients to supervised high-intensity interval training during neoadjuvant chemoradiation therapy followed by unsupervised moderate-to-vigorous exercise after therapy, or usual care. Using the theory of planned behavior, we assessed motivation, perceived benefits/harms, and perceived barriers for exercise during and after therapy. Supervised exercise during neoadjuvant chemo-radiation therapy was experienced as meaningfully (d=0.33) more controllable (p=0.08, d=0.60), more enjoy-able (p=0.25, d=0.45), and less difficult (p=0.45, d=-0.38) than anticipated. Unsupervised exercise after therapy was experienced as meaningfully more enjoyable (p=0.047, d=0.50) and less difficult (p=0.43, d=-0.36), but also less controllable (p=0.14, d=-0.80) than anticipated. Common self-reported benefits of exercise both during and after neoadjuvant chemoradiation therapy were cardiovascular endurance, physical functioning, and quality of life. Common self-reported harms were exacerbation of treatment side effects. Frequently reported barriers to exercise during therapy were side effects of treatment, whereas exercise barriers after therapy were lack of motivation and lingering side effects.Conclusion: Exercise during and after therapy generally had positive effects on exercise motivation, however, perceived harms and barriers related to treatment side effects were identified.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Outcome after neoadjuvant chemoradiation in elderly patients (≥70 years) with rectal cancer
    Dantes, M.
    Isleiwa, R.
    Gerum, S.
    Jensen, A. D.
    Belka, C.
    Roeder, F.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2017, 193 : S134 - S134
  • [42] Efficacy and Feasibility of Adding Induction Chemotherapy to Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer: A Phase II Clinical Trial
    Nasrolahi, Hamid
    Mirzaei, Sepideh
    Mohammadianpanah, Mohammad
    Bananzadeh, Ali Mohammad
    Mokhtari, Maral
    Sasani, Mohammad Reza
    Mosalaei, Ahmad
    Omidvari, Shapour
    Ansari, Mansour
    Ahmadloo, Niloofar
    Hamedi, Seyed Hasan
    Khanjani, Nezhat
    ANNALS OF COLOPROCTOLOGY, 2019, 35 (05) : 242 - 248
  • [43] Outcome after neoadjuvant chemoradiation in elderly patients (≥ 70 years) with rectal cancer
    Roeder, F.
    Dantes, M.
    Isleiwa, R.
    Gerum, S.
    Jensen, A.
    Belka, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S808 - S808
  • [44] A phase II trial of TGFβ type I receptor inhibitor, galunisertib, plus neoadjuvant chemoradiation in patients with locally advanced rectal cancer.
    Young, Kristina Hoot
    Gunderson, Andrew J.
    Gilchrist, Miranda
    Whiteford, Mark
    Kiely, Maria X.
    Hayman, Amanda
    O'Brien, David P.
    Ahmad, Rehan
    Manchio, Jeffrey V.
    Brosnan, Evelyn
    Vaccaro, Gina M.
    Li, Rui
    Simon, Miklos
    McCormick, Mary
    Drokin, Ashley
    Cramer, Julie
    Urba, Walter John
    Gough, Michael
    Crittenden, Marka R.
    Yamazaki, Tomoko
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [45] Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer
    Jiang, Maria
    Raissouni, Soundouss
    Mercer, Jamison
    Kumar, Aalok
    Goodwin, Rachel Anne
    Heng, Daniel Yick Chin
    Tang, Patricia A.
    Doll, Corinne M.
    MacLean, Anthony
    Powell, Erin Diana
    Hiller, Julie A. Price
    Monzon, Jose Gerard
    Vickers, Michael M.
    Cheung, Winson Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [46] Clinical outcomes of elderly patients receiving neoadjuvant chemoradiation for locally advanced rectal cancer
    Jiang, D. M.
    Raissouni, S.
    Mercer, J.
    Kumar, A.
    Goodwin, R.
    Heng, D. Y.
    Tang, P. A.
    Doll, C.
    MacLean, A.
    Powell, E.
    Price-Hiller, J.
    Monzon, J.
    Cheung, W. Y.
    Vickers, M. M.
    ANNALS OF ONCOLOGY, 2015, 26 (10) : 2102 - 2106
  • [47] Outcomes and Prognostic Facors of Rectal Cancer Patients Receiving Neoadjuvant Chemoradiation With and Without Planned
    Chen, H. H.
    Lai, Y.
    Tsai, M.
    Wu, Y.
    Lee, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S393 - S394
  • [48] Curative chemoradiation for low rectal cancer: Primary clinical outcomes from a multicenter phase II trial.
    Jensen, Lars Henrik
    Risum, Signe
    Nielsen, Jesper Dan
    Mynster, Tommie
    Ploeen, John
    Rahr, Hans B.
    Havelund, Birgitte Mayland
    Appelt, Ane L.
    Lindebjerg, Jan
    Rafaelsen, Soeren Rafael
    Jakobsen, Anders
    Poulsen, Laurids
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (17)
  • [49] Intensified Total Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer: A Phase II Trial
    De Felice, F.
    D'Ambrosio, G.
    Iafrate, F.
    Gelibter, A.
    Magliocca, F. M.
    Musio, D.
    Caponetto, S.
    Casella, G.
    Clementi, I
    Picchetto, A.
    Sirgiovani, G.
    Parisi, M.
    Orciuoli, C.
    Torrese, G.
    De Toma, G.
    Tombolini, V
    Cortesi, E.
    CLINICAL ONCOLOGY, 2021, 33 (12) : 788 - 794
  • [50] Determinants of exercise adherence and contamination in a randomized controlled trial in cancer patients during and after allogeneic HCT
    Kuehl, Rea
    Schmidt, Martina E.
    Dreger, Peter
    Steindorf, Karen
    Bohus, Martin
    Wiskemann, Joachim
    SUPPORTIVE CARE IN CANCER, 2016, 24 (10) : 4327 - 4337